*Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Benin
†Chidak Medical Diagnostic Laboratories, 200 M. M. Way, Benin City
‡Department of Microbiology, Faculty of Basic and Applied Sciences, Benson Idahosa University, P.M.B. 1100
§Department of Chemical pathology, Central Hospital, Benin City, Edo State, Nigeria
∥Canadian Research and Development Centre for Probiotics, Lawson Health Research Institute, 268 Grosvenor Street
¶Department of Microbiology and Immunology and Surgery, University of Western Ontario, London, Ontario, Canada
Drs Anukam, Osazuwa and Osadolor have no conflicts.
Dr Reid declares he holds patents for the use of Lactobacillus GR-1 and RC-14 for urogenital health, but not for HIV diarrhea or CD4 applications.
This research is funded in part by Urex Biotech Inc and Natural Sciences and Engineering Research Council of Canada.
Reprints: Dr Gregor Reid, PhD, MBA, Canadian Research and Development Centre for Probiotics, Lawson Health Research Institute, 268 Grosvenor Street, London, Ontario, N6A 4V2 Canada (e-mail: [email protected]).
Received for publication August 17, 2006; accepted October 20, 2006